Overview

This trial is active, not recruiting.

Conditions chronic obstructive pulmonary disease, hypoxia
Treatment oxygen
Sponsor LHL Helse
Start date April 2014
End date March 2016
Trial size 16 participants
Trial identifier NCT02108925, 2013/2396

Summary

The project will test the hypothesis that lung ventilation during exercise is unaffected by oxygen supplementation. In addition, the acute effect of oxygen supplementation on dyspnoea, heart rate and blood pressure will be studied.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Endpoint classification efficacy study
Intervention model single group assignment
Masking double blind (subject, investigator)
Primary purpose treatment
Arm
(Experimental)
Study subjects receive, in randomized order, either supplementary 30% oxygen or air (21% Oxygen) from a gas tight bag
oxygen
supplementary oxygen during exercise

Primary Outcomes

Measure
Pulmonary ventilation
time frame: 1 hour

Secondary Outcomes

Measure
Dyspnoea
time frame: 1 hour
Heart rate
time frame: 1 hour
Blood pressure
time frame: 1 hour

Eligibility Criteria

Male or female participants from 20 years up to 95 years old.

Inclusion Criteria: - Chronic obstructive pulmonary disease Exclusion Criteria: - No exacerbation - No active heart disease

Additional Information

Official title Oxygen Supply and Ventilation During Physical Exercise in Patients With Chronic Obstructive Pulmonary Disease
Principal investigator Anne Edvardsen, PhD
Trial information was received from ClinicalTrials.gov and was last updated in April 2016.
Information provided to ClinicalTrials.gov by LHL Helse.